Postprandial Distress Syndrome (PDS) is a subtype of functional dyspepsia (indigestion) that primarily affects the upper gastrointestinal (GI) tract. Patients typically experience symptoms shortly after eating, which can have a significant impact on food intake, quality of life, and day-to-day wellbeing.

Common symptoms of PDS include: early satiety (feeling full quickly), postprandial fullness, epigastric discomfort or pain, bloating, and nausea.

Although symptoms can be persistent and distressing, PDS is considered a functional disorder, meaning no structural or organic cause is identified during routine investigations.

Despite the strong relationship between food intake and symptom onset, nutrition management of PDS has traditionally been based on relatively general advice.

Current first-line recommendations commonly include:

• Eating smaller, more frequent meals
• Reducing fat intake
• Limiting caffeine and alcohol consumption
• Avoiding spicy, highly processed and high-fat foods
• Reducing carbonated beverages

While these strategies are widely used in practice, robust clinical evidence supporting their effectiveness has been limited.

Researchers recruited 60 adults diagnosed with PDS according to Rome IV criteria. All participants had undergone upper gastrointestinal endoscopy, with no structural abnormalities detected.

Participants were randomly assigned to one of two nutrition interventions for six weeks.

Participants were unaware of the alternative intervention arm (a single-blind study), helping to minimize study bias.

Researchers used several validated tools to assess symptom improvement and quality of life, including:

1. Leuven Postprandial Distress Scale (LPDS)
2. Nepean Dyspepsia Index (NDI)
3. Gastrointestinal Symptom Rating Scale
4. Patient Health Questionnaire
5. Adequate Symptom Relief Assessment

These measures allowed investigators to evaluate both clinical symptoms and broader patient-reported outcomes.

The primary endpoint was improvement in Leuven Postprandial Distress Scale scores. Results favored the low FODMAP diet across all major analyses.

A clinically meaningful reduction in symptoms was achieved by:

• 61% of patients following the low FODMAP diet
• 38% of patients receiving traditional nutrition advice

When a stricter definition of symptom improvement was applied:

• 61% of the low FODMAP group improved
• 21% of the traditional nutrition advice group improved

These findings suggest a substantially greater treatment response with the low FODMAP approach.

Appropriate education and follow-up remain essential to ensure nutritional adequacy and dietary variety.

Although the study strengthens the evidence base for nutrition management of PDS, several limitations should be acknowledged. The trial included only 60 participants and was predominantly female (78%). Ethnic diversity was limited, and outcomes were assessed over a relatively short period of six weeks. In addition, complete participant blinding was not possible and diet adherence relied largely on self-reported measures. As with other studies involving functional gastrointestinal disorders, placebo effects may also have influenced outcomes. Larger sample sizes and longer-term studies are needed to confirm these findings and evaluate sustainability over time.

This landmark trial from the United Kingdom provides compelling evidence that a low FODMAP diet can improve symptoms in patients with Postprandial Distress Syndrome (PDS) more effectively than traditional nutrition advice alone. While first-line nutrition recommendations should remain the starting point for management, a dietitian-led low FODMAP approach may offer significant benefits for patients with ongoing symptoms, complex food sensitivities, or overlapping IBS.